The ECOnti project's aim is to fit the entire manufacturing site into a small footprint as part of bioproduction democratization.

The facility, which will produce cell therapies used to treat cancer and auto immune diseases, creates 150 jobs for highly ...

Careful planning can make a substantial difference on your path to commercial success. Here we delve into key considerations ...

As it applies to the development of cell therapies, AstraZeneca’s chief of global operations, Pam Cheng, admits that the ...

AstraZeneca has opened its first U.S.-operated cell therapy manufacturing plant in Rockville, Maryland, as part of its ongoing $3.5 billion investment in American innovation.

The automated and closed cell therapy processing systems market is experiencing rapid growth, driven by the increasing demand for regenerative medicine and the need for advanced, scalable ...

RoosterBio Inc. has partnered with Thermo Fisher Scientific to accelerate the availability of new, potentially life-saving ...

Roughly two years after securing a former Novartis facility in Illinois to support its CAR-T cancer treatments Breyanzi and ...

Researchers from the Critical Analytics for Manufacturing Personalized-Medicine (CAMP) interdisciplinary research group of ...

Aspen Neuroscience scientists, led by Chief Scientific Officer Xiaokui Zhang, Ph.D., will present at the International ...

I Peace, in Cooperation with SBI Holdings, Unveils Next-Gen Cell Mass-Manufacturing System EGG at SBI Holdings Inc. booth in the Osaka Healthcar ...